nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—Abdominal distress—Methotrexate—muscle cancer	0.0723	0.0723	CcSEcCtD
Pentazocine—Induration—Etoposide—muscle cancer	0.0365	0.0365	CcSEcCtD
Pentazocine—Nodule—Methotrexate—muscle cancer	0.0333	0.0333	CcSEcCtD
Pentazocine—Nystagmus—Vincristine—muscle cancer	0.0282	0.0282	CcSEcCtD
Pentazocine—Ulcer—Dactinomycin—muscle cancer	0.0239	0.0239	CcSEcCtD
Pentazocine—Apnoea—Etoposide—muscle cancer	0.0193	0.0193	CcSEcCtD
Pentazocine—Ulcer—Etoposide—muscle cancer	0.0173	0.0173	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.0148	0.0148	CcSEcCtD
Pentazocine—Urinary retention—Vincristine—muscle cancer	0.0139	0.0139	CcSEcCtD
Pentazocine—Nystagmus—Doxorubicin—muscle cancer	0.0119	0.0119	CcSEcCtD
Pentazocine—Agranulocytosis—Dactinomycin—muscle cancer	0.0118	0.0118	CcSEcCtD
Pentazocine—Apnoea—Methotrexate—muscle cancer	0.0115	0.0115	CcSEcCtD
Pentazocine—Sweating—Vincristine—muscle cancer	0.0108	0.0108	CcSEcCtD
Pentazocine—Erythema multiforme—Dactinomycin—muscle cancer	0.0107	0.0107	CcSEcCtD
Pentazocine—Cramp muscle—Etoposide—muscle cancer	0.0107	0.0107	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.0107	0.0107	CcSEcCtD
Pentazocine—Flushing—Dactinomycin—muscle cancer	0.0105	0.0105	CcSEcCtD
Pentazocine—Ulcer—Methotrexate—muscle cancer	0.0103	0.0103	CcSEcCtD
Pentazocine—Chills—Dactinomycin—muscle cancer	0.0102	0.0102	CcSEcCtD
Pentazocine—Hallucination—Vincristine—muscle cancer	0.0101	0.0101	CcSEcCtD
Pentazocine—Sweating increased—Etoposide—muscle cancer	0.00998	0.00998	CcSEcCtD
Pentazocine—Ulcer—Doxorubicin—muscle cancer	0.00896	0.00896	CcSEcCtD
Pentazocine—Agranulocytosis—Etoposide—muscle cancer	0.00853	0.00853	CcSEcCtD
Pentazocine—Agitation—Vincristine—muscle cancer	0.0081	0.0081	CcSEcCtD
Pentazocine—Vertigo—Vincristine—muscle cancer	0.00792	0.00792	CcSEcCtD
Pentazocine—Erythema multiforme—Etoposide—muscle cancer	0.00776	0.00776	CcSEcCtD
Pentazocine—Anorexia—Dactinomycin—muscle cancer	0.00767	0.00767	CcSEcCtD
Pentazocine—Flushing—Etoposide—muscle cancer	0.00761	0.00761	CcSEcCtD
Pentazocine—Hypertension—Vincristine—muscle cancer	0.00761	0.00761	CcSEcCtD
Pentazocine—Visual disturbance—Methotrexate—muscle cancer	0.00749	0.00749	CcSEcCtD
Pentazocine—Chills—Etoposide—muscle cancer	0.00736	0.00736	CcSEcCtD
Pentazocine—Anaphylactic shock—Vincristine—muscle cancer	0.00719	0.00719	CcSEcCtD
Pentazocine—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00704	0.00704	CcSEcCtD
Pentazocine—Decreased appetite—Dactinomycin—muscle cancer	0.007	0.007	CcSEcCtD
Pentazocine—Dysgeusia—Etoposide—muscle cancer	0.00699	0.00699	CcSEcCtD
Pentazocine—Hyperhidrosis—Vincristine—muscle cancer	0.00695	0.00695	CcSEcCtD
Pentazocine—Muscle spasms—Etoposide—muscle cancer	0.00686	0.00686	CcSEcCtD
Pentazocine—Anorexia—Vincristine—muscle cancer	0.00686	0.00686	CcSEcCtD
Pentazocine—Irritability—Methotrexate—muscle cancer	0.00678	0.00678	CcSEcCtD
Pentazocine—Hypotension—Vincristine—muscle cancer	0.00672	0.00672	CcSEcCtD
Pentazocine—Feeling abnormal—Dactinomycin—muscle cancer	0.00663	0.00663	CcSEcCtD
Pentazocine—Insomnia—Vincristine—muscle cancer	0.00651	0.00651	CcSEcCtD
Pentazocine—Paraesthesia—Vincristine—muscle cancer	0.00646	0.00646	CcSEcCtD
Pentazocine—Vertigo—Etoposide—muscle cancer	0.00641	0.00641	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.0064	0.0064	CcSEcCtD
Pentazocine—Loss of consciousness—Etoposide—muscle cancer	0.00628	0.00628	CcSEcCtD
Pentazocine—Decreased appetite—Vincristine—muscle cancer	0.00625	0.00625	CcSEcCtD
Pentazocine—Hypertension—Etoposide—muscle cancer	0.00616	0.00616	CcSEcCtD
Pentazocine—Constipation—Vincristine—muscle cancer	0.00615	0.00615	CcSEcCtD
Pentazocine—Diplopia—Doxorubicin—muscle cancer	0.00615	0.00615	CcSEcCtD
Pentazocine—Eosinophilia—Methotrexate—muscle cancer	0.00608	0.00608	CcSEcCtD
Pentazocine—Face oedema—Doxorubicin—muscle cancer	0.00594	0.00594	CcSEcCtD
Pentazocine—Hypersensitivity—Dactinomycin—muscle cancer	0.00593	0.00593	CcSEcCtD
Pentazocine—Abdominal discomfort—Methotrexate—muscle cancer	0.00588	0.00588	CcSEcCtD
Pentazocine—Confusional state—Etoposide—muscle cancer	0.00588	0.00588	CcSEcCtD
Pentazocine—Anaphylactic shock—Etoposide—muscle cancer	0.00583	0.00583	CcSEcCtD
Pentazocine—Asthenia—Dactinomycin—muscle cancer	0.00578	0.00578	CcSEcCtD
Pentazocine—Tachycardia—Etoposide—muscle cancer	0.00569	0.00569	CcSEcCtD
Pentazocine—Hyperhidrosis—Etoposide—muscle cancer	0.00563	0.00563	CcSEcCtD
Pentazocine—Anorexia—Etoposide—muscle cancer	0.00555	0.00555	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00554	0.00554	CcSEcCtD
Pentazocine—Diarrhoea—Dactinomycin—muscle cancer	0.00551	0.00551	CcSEcCtD
Pentazocine—Hypotension—Etoposide—muscle cancer	0.00545	0.00545	CcSEcCtD
Pentazocine—Hypersensitivity—Vincristine—muscle cancer	0.0053	0.0053	CcSEcCtD
Pentazocine—Eosinophilia—Doxorubicin—muscle cancer	0.00526	0.00526	CcSEcCtD
Pentazocine—Sweating—Methotrexate—muscle cancer	0.00525	0.00525	CcSEcCtD
Pentazocine—Paraesthesia—Etoposide—muscle cancer	0.00523	0.00523	CcSEcCtD
Pentazocine—Dyspnoea—Etoposide—muscle cancer	0.0052	0.0052	CcSEcCtD
Pentazocine—Somnolence—Etoposide—muscle cancer	0.00518	0.00518	CcSEcCtD
Pentazocine—Asthenia—Vincristine—muscle cancer	0.00516	0.00516	CcSEcCtD
Pentazocine—Vomiting—Dactinomycin—muscle cancer	0.00512	0.00512	CcSEcCtD
Pentazocine—Agranulocytosis—Methotrexate—muscle cancer	0.00511	0.00511	CcSEcCtD
Pentazocine—Decreased appetite—Etoposide—muscle cancer	0.00507	0.00507	CcSEcCtD
Pentazocine—Constipation—Etoposide—muscle cancer	0.00498	0.00498	CcSEcCtD
Pentazocine—Diarrhoea—Vincristine—muscle cancer	0.00492	0.00492	CcSEcCtD
Pentazocine—Feeling abnormal—Etoposide—muscle cancer	0.0048	0.0048	CcSEcCtD
Pentazocine—Nausea—Dactinomycin—muscle cancer	0.00478	0.00478	CcSEcCtD
Pentazocine—Dizziness—Vincristine—muscle cancer	0.00476	0.00476	CcSEcCtD
Pentazocine—Visual impairment—Methotrexate—muscle cancer	0.00473	0.00473	CcSEcCtD
Pentazocine—Erythema multiforme—Methotrexate—muscle cancer	0.00465	0.00465	CcSEcCtD
Pentazocine—Tinnitus—Methotrexate—muscle cancer	0.00458	0.00458	CcSEcCtD
Pentazocine—Vomiting—Vincristine—muscle cancer	0.00457	0.00457	CcSEcCtD
Pentazocine—Sweating—Doxorubicin—muscle cancer	0.00454	0.00454	CcSEcCtD
Pentazocine—Dermatitis—Vincristine—muscle cancer	0.00453	0.00453	CcSEcCtD
Pentazocine—Headache—Vincristine—muscle cancer	0.00451	0.00451	CcSEcCtD
Pentazocine—Agranulocytosis—Doxorubicin—muscle cancer	0.00442	0.00442	CcSEcCtD
Pentazocine—Chills—Methotrexate—muscle cancer	0.00441	0.00441	CcSEcCtD
Pentazocine—Hypersensitivity—Etoposide—muscle cancer	0.00429	0.00429	CcSEcCtD
Pentazocine—Nausea—Vincristine—muscle cancer	0.00427	0.00427	CcSEcCtD
Pentazocine—Dysgeusia—Methotrexate—muscle cancer	0.00419	0.00419	CcSEcCtD
Pentazocine—Asthenia—Etoposide—muscle cancer	0.00418	0.00418	CcSEcCtD
Pentazocine—Pruritus—Etoposide—muscle cancer	0.00412	0.00412	CcSEcCtD
Pentazocine—Visual impairment—Doxorubicin—muscle cancer	0.0041	0.0041	CcSEcCtD
Pentazocine—Vision blurred—Methotrexate—muscle cancer	0.00403	0.00403	CcSEcCtD
Pentazocine—Erythema multiforme—Doxorubicin—muscle cancer	0.00402	0.00402	CcSEcCtD
Pentazocine—Diarrhoea—Etoposide—muscle cancer	0.00399	0.00399	CcSEcCtD
Pentazocine—Tinnitus—Doxorubicin—muscle cancer	0.00397	0.00397	CcSEcCtD
Pentazocine—Flushing—Doxorubicin—muscle cancer	0.00395	0.00395	CcSEcCtD
Pentazocine—Dizziness—Etoposide—muscle cancer	0.00385	0.00385	CcSEcCtD
Pentazocine—Vertigo—Methotrexate—muscle cancer	0.00384	0.00384	CcSEcCtD
Pentazocine—Chills—Doxorubicin—muscle cancer	0.00382	0.00382	CcSEcCtD
Pentazocine—Vomiting—Etoposide—muscle cancer	0.00371	0.00371	CcSEcCtD
Pentazocine—Dermatitis—Etoposide—muscle cancer	0.00367	0.00367	CcSEcCtD
Pentazocine—Headache—Etoposide—muscle cancer	0.00365	0.00365	CcSEcCtD
Pentazocine—Dysgeusia—Doxorubicin—muscle cancer	0.00363	0.00363	CcSEcCtD
Pentazocine—Muscle spasms—Doxorubicin—muscle cancer	0.00356	0.00356	CcSEcCtD
Pentazocine—Confusional state—Methotrexate—muscle cancer	0.00352	0.00352	CcSEcCtD
Pentazocine—Anaphylactic shock—Methotrexate—muscle cancer	0.00349	0.00349	CcSEcCtD
Pentazocine—Vision blurred—Doxorubicin—muscle cancer	0.00349	0.00349	CcSEcCtD
Pentazocine—Nausea—Etoposide—muscle cancer	0.00346	0.00346	CcSEcCtD
Pentazocine—Agitation—Doxorubicin—muscle cancer	0.0034	0.0034	CcSEcCtD
Pentazocine—Hyperhidrosis—Methotrexate—muscle cancer	0.00337	0.00337	CcSEcCtD
Pentazocine—Vertigo—Doxorubicin—muscle cancer	0.00333	0.00333	CcSEcCtD
Pentazocine—Anorexia—Methotrexate—muscle cancer	0.00333	0.00333	CcSEcCtD
Pentazocine—Syncope—Doxorubicin—muscle cancer	0.00332	0.00332	CcSEcCtD
Pentazocine—Hypotension—Methotrexate—muscle cancer	0.00326	0.00326	CcSEcCtD
Pentazocine—Loss of consciousness—Doxorubicin—muscle cancer	0.00325	0.00325	CcSEcCtD
Pentazocine—Hypertension—Doxorubicin—muscle cancer	0.0032	0.0032	CcSEcCtD
Pentazocine—Insomnia—Methotrexate—muscle cancer	0.00316	0.00316	CcSEcCtD
Pentazocine—Paraesthesia—Methotrexate—muscle cancer	0.00313	0.00313	CcSEcCtD
Pentazocine—Dyspnoea—Methotrexate—muscle cancer	0.00311	0.00311	CcSEcCtD
Pentazocine—Somnolence—Methotrexate—muscle cancer	0.0031	0.0031	CcSEcCtD
Pentazocine—Dry mouth—Doxorubicin—muscle cancer	0.00308	0.00308	CcSEcCtD
Pentazocine—Confusional state—Doxorubicin—muscle cancer	0.00305	0.00305	CcSEcCtD
Pentazocine—Decreased appetite—Methotrexate—muscle cancer	0.00303	0.00303	CcSEcCtD
Pentazocine—Anaphylactic shock—Doxorubicin—muscle cancer	0.00302	0.00302	CcSEcCtD
Pentazocine—Shock—Doxorubicin—muscle cancer	0.00297	0.00297	CcSEcCtD
Pentazocine—Tachycardia—Doxorubicin—muscle cancer	0.00295	0.00295	CcSEcCtD
Pentazocine—Hyperhidrosis—Doxorubicin—muscle cancer	0.00292	0.00292	CcSEcCtD
Pentazocine—Anorexia—Doxorubicin—muscle cancer	0.00288	0.00288	CcSEcCtD
Pentazocine—Feeling abnormal—Methotrexate—muscle cancer	0.00288	0.00288	CcSEcCtD
Pentazocine—Hypotension—Doxorubicin—muscle cancer	0.00282	0.00282	CcSEcCtD
Pentazocine—Insomnia—Doxorubicin—muscle cancer	0.00273	0.00273	CcSEcCtD
Pentazocine—Paraesthesia—Doxorubicin—muscle cancer	0.00271	0.00271	CcSEcCtD
Pentazocine—Dyspnoea—Doxorubicin—muscle cancer	0.00269	0.00269	CcSEcCtD
Pentazocine—Somnolence—Doxorubicin—muscle cancer	0.00269	0.00269	CcSEcCtD
Pentazocine—Decreased appetite—Doxorubicin—muscle cancer	0.00263	0.00263	CcSEcCtD
Pentazocine—Constipation—Doxorubicin—muscle cancer	0.00258	0.00258	CcSEcCtD
Pentazocine—Hypersensitivity—Methotrexate—muscle cancer	0.00257	0.00257	CcSEcCtD
Pentazocine—Asthenia—Methotrexate—muscle cancer	0.0025	0.0025	CcSEcCtD
Pentazocine—Feeling abnormal—Doxorubicin—muscle cancer	0.00249	0.00249	CcSEcCtD
Pentazocine—Pruritus—Methotrexate—muscle cancer	0.00247	0.00247	CcSEcCtD
Pentazocine—Diarrhoea—Methotrexate—muscle cancer	0.00239	0.00239	CcSEcCtD
Pentazocine—Dizziness—Methotrexate—muscle cancer	0.00231	0.00231	CcSEcCtD
Pentazocine—Hypersensitivity—Doxorubicin—muscle cancer	0.00223	0.00223	CcSEcCtD
Pentazocine—Vomiting—Methotrexate—muscle cancer	0.00222	0.00222	CcSEcCtD
Pentazocine—Dermatitis—Methotrexate—muscle cancer	0.0022	0.0022	CcSEcCtD
Pentazocine—Headache—Methotrexate—muscle cancer	0.00219	0.00219	CcSEcCtD
Pentazocine—Asthenia—Doxorubicin—muscle cancer	0.00217	0.00217	CcSEcCtD
Pentazocine—Pruritus—Doxorubicin—muscle cancer	0.00214	0.00214	CcSEcCtD
Pentazocine—Nausea—Methotrexate—muscle cancer	0.00207	0.00207	CcSEcCtD
Pentazocine—Diarrhoea—Doxorubicin—muscle cancer	0.00207	0.00207	CcSEcCtD
Pentazocine—Dizziness—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Pentazocine—Vomiting—Doxorubicin—muscle cancer	0.00192	0.00192	CcSEcCtD
Pentazocine—Dermatitis—Doxorubicin—muscle cancer	0.0019	0.0019	CcSEcCtD
Pentazocine—Headache—Doxorubicin—muscle cancer	0.00189	0.00189	CcSEcCtD
Pentazocine—Nausea—Doxorubicin—muscle cancer	0.0018	0.0018	CcSEcCtD
